Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | S100A4 | P26447 | 1/20 | 0.52 |
| ▸ | MTOR | P42345 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.52 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28653034 | 0.90 | GAA (0.45) | GAAALDH1A1TDP1MAPTCYP3A4 | |
| SCHEMBL27381634 | 0.82 | GAA (0.42) | GAAALDH1A1TDP1MAPTCYP3A4 | |
| SCHEMBL28577615 | 0.80 | GAA (0.59) | GAAALDH1A1TDP1MAPTCYP3A4 | |
| SCHEMBL6585722 | 0.78 | GAA (0.56) | GAAALDH1A1TDP1MAPTCYP3A4 | |
| P-Xylene SCHEMBL11183319 | 0.77 | ALDH1A1 (0.48) | GAAALDH1A1TDP1MAPTCYP3A4 | |
| SCHEMBL14018160 | 0.76 | MMP2 (0.45) | ALDH1A1MEN1KMT2ACA1CA2 | |
| SCHEMBL1721592 | 0.76 | GAA (0.54) | GAAALDH1A1TDP1MAPTCYP3A4 | |
| SCHEMBL12017078 | 0.76 | CA2 (0.50) | MAPK1CA1CA2CA12CA9 | |
| SCHEMBL9273311 | 0.76 | ALDH1A1 (0.54) | ALDH1A1CYP3A4NPC1MEN1HPGD | |
| SCHEMBL360697 | 0.76 | GAA (0.54) | GAAALDH1A1TDP1MAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1081 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215019-A1 | ORTHOGONAL FUNCTIONALIZATION OF BRIDGE-SUBSTITUTED BCPS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-07-03 | — | — | US | claimed |
| CN-113549120-B | Method for preparing ribonucleoside | 吉利德科学公司 | 2025-04-29 | — | — | CN | claimed |
| CN-115340503-B | Synthesis method and application of chiral semicorrinoid compound | 四川师范大学 | 2024-12-24 | — | — | CN | claimed |
| CN-117645581-A | Method for synthesizing series of functional groups of photocatalytic inert C (sp 3) -H bond | 浙江工业大学台州研究院 | 2024-03-05 | — | — | CN | claimed |
| WO-2023183757-A2 | ORTHOGONAL FUNCTIONALIZATION OF BRIDGE-SUBSTITUTED BCPS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-09-28 | — | — | WO | claimed |
| CN-116444330-A | Addition product of alkyl free radical and capture reagent, addition method and application thereof | 深圳湾实验室坪山生物医药研发转化中心 | 2023-07-18 | — | — | CN | claimed |
| CN-115340503-A | Synthetic method and application of chiral hemicorrin compound | 四川师范大学 | 2022-11-15 | — | — | CN | claimed |
| CN-111233869-B | Novel compound for preparing Rudexilvir key intermediate and preparation method thereof | 杭州新博思生物医药有限公司 | 2022-09-16 | — | — | CN | claimed |
| EP-4026837-A1 | PROCESS FOR PRODUCING 2,5-DIAMINO-2,5-DIDEOXY-1,4:3,6-DIANHYDROHEXITOL | Covestro Deutschland AG (DE) | 2022-07-13 | — | — | EP | claimed |
| CN-110165175-B | High-nickel ternary cathode material and preparation method and application thereof | 合肥国轩高科动力能源有限公司 | 2022-03-11 | — | — | CN | claimed |
| US-20080214528-A1 | ANTI-INFECTIVE AGENTS | ABBVIE INC. | 2008-09-04 | — | — | US | claimed |
| WO-2008011337-A1 | HCV INHIBITORS | ABBOTT LABORATORIES (US) | 2008-01-24 | — | — | WO | claimed |
| EP-0926136-B1 | Process for producing and method of crystallizing 2-azabicyclo(2.2.1)hept-5-en-3-one | KURARAY CO (JP) | 2004-05-12 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0926136-A2 | Process for producing and method of crystallizing 2-azabicyclo(2.2.1)hept-5-en-3-one | KURARAY CO., LTD. (JP) | 1999-06-30 | — | — | EP | claimed |
| EP-0713490-B1 | C-22 RING STABILIZED RAPAMYCIN DERIVATIVES | AMERICAN HOME PROD (US) | 1998-02-25 | — | — | EP | claimed |
| EP-0303636-B1 | A PROCESS FOR THE PREPARATION OF PYRETHROID TYPE ESTER COMPOUNDS | LUCKY, LTD. (KR) | 1992-05-13 | — | — | EP | claimed |
| EP-0196707-B1 | 19-NOR STEROIDS SUBSTITUTED AT POSITIONS 11 AND 17 AND OPTIONALLY AT POSITION 2, THEIR PREPARATION, THEIR USE AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES OBTAINED | ROUSSEL-UCLAF (FR) | 1989-09-27 | — | — | EP | claimed |
| EP-0097572-B1 | 19-NOR STEROIDS SUBSTITUTED AT POSITION 11 AND OPTIONALLY AT POSITION 2, THEIR PREPARATION, THEIR UTILIZATION AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM AND INTERMEDIATES OBTAINED | ROUSSEL-UCLAF (FR) | 1986-11-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215019-A1 | ORTHOGONAL FUNCTIONALIZATION OF BRIDGE-SUBSTITUTED BCPS | BMP2, BMP4, DCX | GAA 4189/4885ALDH1A1 1282/4885TDP1 4142/4885 |
| US-20080214528-A1 | ANTI-INFECTIVE AGENTS | NQO2, RSU1, RRS1 | GAA 3089/4885ALDH1A1 1406/4885TDP1 2855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.